Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta-Analysis of Prospective Studies
- PMID: 39742021
- PMCID: PMC11213638
- DOI: 10.1155/2024/9944490
Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta-Analysis of Prospective Studies
Abstract
Background: In this systematic review and meta-analysis, we aimed to validate the predictive role of atrial fibrillation (AF) termination in long-term arrhythmia recurrence. Method: Our search encompassed databases including MEDLINE, EMBASE, PubMed, and the Cochrane Library up to August 1, 2021. Three independent reviewers conducted screening and data extraction. The data included ablation strategy, recurrence mode, AF termination mode, numbers of patients, and recurrence cases in the termination and nontermination groups. The primary endpoint was the recurrence of atrial arrhythmia at long-term follow-up (≥ 12 months). Results: Our analysis included 22 publications, with 11 prospective studies being eligible for further meta-analysis. Among these, 14 studies reported significantly lower rates of arrhythmia recurrence in the AF termination group compared to the nontermination group. Among seven studies involving 1114 patients that examined single procedure outcomes, the pooled estimated effect was RR 0.78 (95% CI 0.68-1.90) with an I 2 value of 57%. Subgroup analysis focusing on termination mode as sinus rhythm yielded a pooled estimated effect of RR 0.74 (95% CI 0.59-0.92) with an I 2 value of 47%. Additionally, analysis of seven studies involving 1433 patients for repeat procedures demonstrated a significant preference for the AF termination group (RR 0.83, 95% CI 0.71-0.97, I 2 = 84%). Subgroup analysis indicated reduced heterogeneity when the termination mode was sinus rhythm (RR 0.68, 95% CI 0.51-0.90, I 2 = 57%). Conclusion: Our study establishes that AF termination serves as an effective predictor for the success of persistent AF ablation procedures. This finding holds potential implications for clinical practice and contributes to our understanding of long-term arrhythmia recurrence in the context of AF termination.
Keywords: atrial fibrillation; catheter ablation; recurrence; termination.
Copyright © 2024 Jialing He et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Catheter ablation for paroxysmal and persistent atrial fibrillation.Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD007101. doi: 10.1002/14651858.CD007101.pub2. Cochrane Database Syst Rev. 2012. PMID: 22513945 Free PMC article.
-
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2. Cochrane Database Syst Rev. 2021. PMID: 34674223 Free PMC article.
-
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD012088. doi: 10.1002/14651858.CD012088.pub2. Cochrane Database Syst Rev. 2016. PMID: 27871122 Free PMC article.
-
Impact of Recurrence-to-Repeat Ablation Time on Long-Term Efficacy and Safety of Patients With Paroxysmal Atrial Fibrillation: Time Matters.J Cardiovasc Electrophysiol. 2025 Aug;36(8):1849-1857. doi: 10.1111/jce.16742. Epub 2025 May 27. J Cardiovasc Electrophysiol. 2025. PMID: 40421629
-
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340. Health Technol Assess. 2008. PMID: 19036232
Cited by
-
Effectiveness and Safety of Dose-Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.Cardiovasc Ther. 2025 Jan 6;2025:9923772. doi: 10.1155/cdr/9923772. eCollection 2025. Cardiovasc Ther. 2025. PMID: 39817158 Free PMC article.
References
-
- Hindricks G., Potpara T., Dagres N., et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal . 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical